A Breakthrough for Depression Treatment: FDA Fast Tracks atai’s Novel Nasal Spray
The FDA has granted Breakthrough Therapy designation to BPL-003, a nasal spray that could transform treatment for patients whose depression
Read More
The FDA has granted Breakthrough Therapy designation to BPL-003, a nasal spray that could transform treatment for patients whose depression
Read More
Do you know what differentiates ayahuasca vs. DMT? You should.
Read More
What does anxiety feel like both physically and mentally? Dr. Jonathann Kuo from Hudson Mind helps explain.
Read More
Despite getting denied by the FDA, this funding to study MDMA therapy for PTSD represents a significant step forward.
Read More
The study concluded that microdosing LSD did not significantly improve ADHD symptoms compared to a placebo.
Read More
VA Secretary Doug Collins continues his passionate advocacy for psychedelic therapy access to achieve genuine healing for America's veterans.
Read More
New insights: Should psychotherapy happen during the ketamine session, immediately after, or the following day?
Read More
Is MDMA therapy the future of PTSD treatment?
Read More
During a psychedelic trip, these are the brain functions most impacted.
Read More
“Psychedelics don’t care if you are using them for recreation, therapy, or ceremony–they will give you what they have to
Read More